Cite
HARVARD Citation
Noviello, S. et al. (2020). A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infections. Journal of medical microbiology. 69 (4), pp. 625-630. [Online].